Genius Brands Intl (NASDAQ:GNUS) reported $21.20 million in sales this quarter. This is a 805.21 percent increase over sales of $2.34 million the same period last year.
Related Posts
JP Morgan Upgrades Melco Resorts and Enter to Overweight, Raises Price Target to $10
JP Morgan analyst Joseph Greff upgrades Melco Resorts and Enter (NASDAQ:MLCO) from Neutral to Overweight and raises the price target from $7 to $10.
Despite Hitting Mid-Stage Trial Endpoint Goal, Vertex Strikes Out Rare Lung Disease Candidate; Stock Tumbles
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) announced the Phase 2 data evaluating VX-864 in alpha-1 antitrypsin deficiency (AATD) with the PiZZ genotype.
Lineage Cell Therapeutics’s Earnings: A Preview
Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-03-10. Here's what investors need to know before the announcement.
Analysts estimate that Lineage Cell Therapeutics will report an earnings per share (EPS) of $-0.05.